{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:17:28Z","timestamp":1779221848437,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Mexican National Council for Science and Technology","award":["Fon.Inst.\/58\/2016"],"award-info":[{"award-number":["Fon.Inst.\/58\/2016"]}]},{"name":"CONACyT","award":["Fon.Inst.\/58\/2016"],"award-info":[{"award-number":["Fon.Inst.\/58\/2016"]}]},{"name":"CONACyT","award":["253053"],"award-info":[{"award-number":["253053"]}]}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.tube.2016.05.015","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T15:11:39Z","timestamp":1466262699000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Efficacy of gene-therapy based on adenovirus encoding granulocyte-macrophage colony-stimulating factor in drug-sensitive and drug-resistant experimental pulmonary tuberculosis"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1558-8084","authenticated-orcid":false,"given":"Alejandro","family":"Francisco-Cruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulce","family":"Mata-Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavio","family":"Ramos-Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Marquina-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Estrada-Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogelio","family":"Hern\u00e1ndez-Pando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2016.05.015_bib1","series-title":"Global tuberculosis report","author":"WHO","year":"2015"},{"key":"10.1016\/j.tube.2016.05.015_bib2","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1371\/journal.pmed.0040238","article-title":"Patient adherence to tuberculosis treatment: a systematic review of qualitative research","volume":"4","author":"Munro","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.tube.2016.05.015_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.46.2.267-274.2002","article-title":"Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective","volume":"46","author":"Gillespie","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2016.05.015_bib4","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJM199206043262302","article-title":"An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome","volume":"326","author":"Edlin","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.tube.2016.05.015_bib5","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1093\/infdis\/jis197","article-title":"Adjunct immunotherapies for tuberculosis","volume":"205","author":"Uhlin","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2016.05.015_bib6","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/j.ijid.2011.05.002","article-title":"Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review","volume":"15","author":"Gao","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tube.2016.05.015_bib7","doi-asserted-by":"crossref","first-page":"e6984","DOI":"10.1371\/journal.pone.0006984","article-title":"Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis","volume":"4","author":"Dawson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.05.015_bib8","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/jps.22054","article-title":"Delivery of therapeutic proteins","volume":"99","author":"Pisal","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.tube.2016.05.015_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/2042098611406318","article-title":"Immunogenicity and other problems associated with the use of biopharmaceuticals","volume":"2","author":"Tovey","year":"2011","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.tube.2016.05.015_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1440-1711.2006.01420.x","article-title":"Genetic susceptibility to mycobacterial disease in humans","volume":"84","author":"Fernando","year":"2006","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.tube.2016.05.015_bib11","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S1472-9792(09)70005-8","article-title":"Pulmonary surfactant and tuberculosis","volume":"89","author":"Chroneos","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2016.05.015_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tube.2007.08.009","article-title":"Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis","volume":"88","author":"Szeliga","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2016.05.015_bib13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s12032-013-0774-6","article-title":"Granulocyte-macrophage colony-stimulating factor: not just another haematopoietic growth factor","volume":"31","author":"Francisco-Cruz","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.tube.2016.05.015_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ni.1990","article-title":"IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses","volume":"12","author":"Krausgruber","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.tube.2016.05.015_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00281-013-0388-2","article-title":"Macrophages in tuberculosis: friend or foe","volume":"35","author":"Guirado","year":"2013","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.tube.2016.05.015_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/08977190412331279881","article-title":"GM-CSF biology","volume":"22","author":"Hamilton","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.tube.2016.05.015_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cei.12015","article-title":"Immunotherapeutic effects of recombinant adenovirus encoding granulocyte-macrophage colony-stimulating factor in experimental pulmonary tuberculosis","volume":"171","author":"Francisco-Cruz","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2016.05.015_bib18","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1016\/j.bmcl.2009.07.147","article-title":"Simple dihydrosphyngosine analogues with potent activity against MDR-Mycobacterium tuberculosis","volume":"19","author":"Del Olmo","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2016.05.015_bib19","first-page":"26","article-title":"Correlation between the kinetics of Th1\/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis","volume":"89","author":"Hern\u00e1ndez-Pando","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2016.05.015_bib20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2567.1997.00193.x","article-title":"Analysis of the local kinetics and localization of interleukin-1a, tumor necrosis factor-a and transforming growth factor-b, during the course of experimental pulmonary tuberculosis","volume":"90","author":"Hern\u00e1ndez-Pando","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2016.05.015_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1574-695X.1995.tb00176.x","article-title":"Adrenal changes in murine pulmonary tuberculosis; a clue to pathogenesis?","volume":"12","author":"Hernandez-Pando","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.tube.2016.05.015_bib22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI118503","article-title":"Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions","volume":"97","author":"Xing","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.tube.2016.05.015_bib23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ccm.2009.08.009","article-title":"Advances in immunotherapy for tuberculosis treatment","volume":"30","author":"Churchyard","year":"2009","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.tube.2016.05.015_bib24","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(96)12273-X","article-title":"Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol","volume":"349","author":"Condos","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2016.05.015_bib25","first-page":"99","article-title":"Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis","volume":"11","author":"Giosu\u00e8","year":"2000","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.tube.2016.05.015_bib26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/mt.2008.69","article-title":"Therapeutic effect of recombinant adenovirus encoding interferon-gamma in a murine model of progressive pulmonary tuberculosis","volume":"16","author":"Mata-Espinosa","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.tube.2016.05.015_bib27","doi-asserted-by":"crossref","first-page":"205ra134","DOI":"10.1126\/scitranslmed.3006843","article-title":"A\u00a0human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity","volume":"5","author":"Smaill","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tube.2016.05.015_bib28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1586\/14760584.2014.929947","article-title":"Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future?","volume":"13","author":"Smaill","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tube.2016.05.015_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.virol.2009.08.038","article-title":"Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents","volume":"394","author":"Shashkova","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.tube.2016.05.015_bib30","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1172\/JCI57235","article-title":"In\u00a0vitro differentiation of human macrophages with enhanced antimycobacterial activity","volume":"121","author":"Vogt","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.tube.2016.05.015_bib31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1086\/315191","article-title":"Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes\/macrophages in\u00a0vitro and in\u00a0vivo","volume":"181","author":"Kedzierska","year":"2000","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2016.05.015_bib32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.00760-07","article-title":"Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis","volume":"52","author":"Quezada","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2016.05.015_bib33","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.V95.7.2337","article-title":"Transgenic expression of granulocyte-macrophage colony-stimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung","volume":"95","author":"Wang","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tube.2016.05.015_bib34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2567.2004.01904.x","article-title":"Airways infection with virulent Mycobacterium tuberculosis delays the influx of dendritic cells and the expression of costimulatory molecules in mediastinal lymph nodes","volume":"112","author":"Garc\u00eda-Romo","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2016.05.015_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1590\/S1413-86702003000400004","article-title":"Use of Rhu-GM-CSF in pulmonary tuberculosis patients: results of a randomized clinical trial","volume":"7","author":"Pedral-Sampaio","year":"2003","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.tube.2016.05.015_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0966-842X(98)01216-5","article-title":"Mechanisms of latency in Mycobacterium tuberculosis","volume":"6","author":"Parrish","year":"1998","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.tube.2016.05.015_bib37","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1473-3099(03)00741-2","article-title":"Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection","volume":"3","author":"Tufariello","year":"2003","journal-title":"Lancet Infect Dis"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T14:35:18Z","timestamp":1600785318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979215302766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":37,"alternative-id":["S1472979215302766"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2016.05.015","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of gene-therapy based on adenovirus encoding granulocyte-macrophage colony-stimulating factor in drug-sensitive and drug-resistant experimental pulmonary tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2016.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}